International comparison of trends in patients commencing renal replacement therapy by primary renal disease

Research output: Contribution to journalArticle

Standard

International comparison of trends in patients commencing renal replacement therapy by primary renal disease. / Stel, Vianda S.; Awadhpersad, Ryan; Pippias, Maria; Ferrer-Alamar, Manuel; Finne, Patrik; Fraser, Simon D.; Heaf, James G.; Hemmelder, Marc H.; Martínez-Castelao, Alberto; de Meester, Johan; Palsson, Runolfur; Prischl, Friedrich C.; Segelmark, Mårten; Traynor, Jamie P.; Santamaria, Rafael; Reisæter, Anna Varberg; Massy, Ziad A.; Jager, Kitty J.

In: Nephrology, Vol. 24, No. 10, 2019, p. 1064-1076.

Research output: Contribution to journalArticle

Harvard

Stel, VS, Awadhpersad, R, Pippias, M, Ferrer-Alamar, M, Finne, P, Fraser, SD, Heaf, JG, Hemmelder, MH, Martínez-Castelao, A, de Meester, J, Palsson, R, Prischl, FC, Segelmark, M, Traynor, JP, Santamaria, R, Reisæter, AV, Massy, ZA & Jager, KJ 2019, 'International comparison of trends in patients commencing renal replacement therapy by primary renal disease', Nephrology, vol. 24, no. 10, pp. 1064-1076. https://doi.org/10.1111/nep.13531

APA

Stel, V. S., Awadhpersad, R., Pippias, M., Ferrer-Alamar, M., Finne, P., Fraser, S. D., ... Jager, K. J. (2019). International comparison of trends in patients commencing renal replacement therapy by primary renal disease. Nephrology, 24(10), 1064-1076. https://doi.org/10.1111/nep.13531

CBE

Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, Heaf JG, Hemmelder MH, Martínez-Castelao A, de Meester J, Palsson R, Prischl FC, Segelmark M, Traynor JP, Santamaria R, Reisæter AV, Massy ZA, Jager KJ. 2019. International comparison of trends in patients commencing renal replacement therapy by primary renal disease. Nephrology. 24(10):1064-1076. https://doi.org/10.1111/nep.13531

MLA

Vancouver

Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD et al. International comparison of trends in patients commencing renal replacement therapy by primary renal disease. Nephrology. 2019;24(10):1064-1076. https://doi.org/10.1111/nep.13531

Author

Stel, Vianda S. ; Awadhpersad, Ryan ; Pippias, Maria ; Ferrer-Alamar, Manuel ; Finne, Patrik ; Fraser, Simon D. ; Heaf, James G. ; Hemmelder, Marc H. ; Martínez-Castelao, Alberto ; de Meester, Johan ; Palsson, Runolfur ; Prischl, Friedrich C. ; Segelmark, Mårten ; Traynor, Jamie P. ; Santamaria, Rafael ; Reisæter, Anna Varberg ; Massy, Ziad A. ; Jager, Kitty J. / International comparison of trends in patients commencing renal replacement therapy by primary renal disease. In: Nephrology. 2019 ; Vol. 24, No. 10. pp. 1064-1076.

RIS

TY - JOUR

T1 - International comparison of trends in patients commencing renal replacement therapy by primary renal disease

AU - Stel, Vianda S.

AU - Awadhpersad, Ryan

AU - Pippias, Maria

AU - Ferrer-Alamar, Manuel

AU - Finne, Patrik

AU - Fraser, Simon D.

AU - Heaf, James G.

AU - Hemmelder, Marc H.

AU - Martínez-Castelao, Alberto

AU - de Meester, Johan

AU - Palsson, Runolfur

AU - Prischl, Friedrich C.

AU - Segelmark, Mårten

AU - Traynor, Jamie P.

AU - Santamaria, Rafael

AU - Reisæter, Anna Varberg

AU - Massy, Ziad A.

AU - Jager, Kitty J.

PY - 2019

Y1 - 2019

N2 - Aim: To examine international time trends in the incidence of renal replacement therapy (RRT) for end-stage renal disease (ESRD) by primary renal disease (PRD). Methods: Renal registries reporting on patients starting RRT per million population for ESRD by PRD from 2005 to 2014, were identified by internet search and literature review. The average annual percentage change (AAPC) with a 95% confidence interval (CI) of the time trends was computed using Joinpoint regression. Results: There was a significant decrease in the incidence of RRT for ESRD due to diabetes mellitus (DM) in Europe (AAPC = −0.9; 95%CI −1.3; −0.5) and to hypertension/renal vascular disease (HT/RVD) in Australia (AAPC = −1.8; 95%CI −3.3; −0.3), Canada (AAPC = −2.9; 95%CI −4.4; −1.5) and Europe (AAPC = −1.1; 95%CI −2.1; −0.0). A decrease or stabilization was observed for glomerulonephritis in all regions and for autosomal dominant polycystic kidney disease (ADPKD) in all regions except for Malaysia and the Republic of Korea. An increase of 5.2–16.3% was observed for DM, HT/RVD and ADPKD in Malaysia and the Republic of Korea. Conclusion: Large international differences exist in the trends in incidence of RRT by primary renal disease. Mapping of these international trends is the first step in defining the causes and successful preventative measures of CKD.

AB - Aim: To examine international time trends in the incidence of renal replacement therapy (RRT) for end-stage renal disease (ESRD) by primary renal disease (PRD). Methods: Renal registries reporting on patients starting RRT per million population for ESRD by PRD from 2005 to 2014, were identified by internet search and literature review. The average annual percentage change (AAPC) with a 95% confidence interval (CI) of the time trends was computed using Joinpoint regression. Results: There was a significant decrease in the incidence of RRT for ESRD due to diabetes mellitus (DM) in Europe (AAPC = −0.9; 95%CI −1.3; −0.5) and to hypertension/renal vascular disease (HT/RVD) in Australia (AAPC = −1.8; 95%CI −3.3; −0.3), Canada (AAPC = −2.9; 95%CI −4.4; −1.5) and Europe (AAPC = −1.1; 95%CI −2.1; −0.0). A decrease or stabilization was observed for glomerulonephritis in all regions and for autosomal dominant polycystic kidney disease (ADPKD) in all regions except for Malaysia and the Republic of Korea. An increase of 5.2–16.3% was observed for DM, HT/RVD and ADPKD in Malaysia and the Republic of Korea. Conclusion: Large international differences exist in the trends in incidence of RRT by primary renal disease. Mapping of these international trends is the first step in defining the causes and successful preventative measures of CKD.

KW - diabetes mellitus

KW - hypertension

KW - primary renal disease

KW - renal replacement therapy

KW - trends

KW - worldwide

U2 - 10.1111/nep.13531

DO - 10.1111/nep.13531

M3 - Article

VL - 24

SP - 1064

EP - 1076

JO - Nephrology

JF - Nephrology

SN - 1320-5358

IS - 10

ER -